Subsidised oocyte donation in Israel (1998–2000): results, costs and lessons

• Published in: Human reproduction (Oxford) Vol. 17; no. 5; pp. 1404 - 1406
• Main Authors: Rabinerson, D., Dekel, A., Orvieto, R., Feldberg, D., Simon, D., Kaplan, B.
• Format: Journal Article
• Language: English
• Published: Oxford Oxford University Press 01.05.2002
• Subjects: Bioethics; Biological and medical sciences; Birth control; Birth Rate; cycles; Female; Financing, Government - legislation & jurisprudence; Gynecology. Andrology. Obstetrics; Health Care Costs; Humans; insurance; Israel; Medical sciences; Middle Aged; oocyte donation; Oocyte Donation - economics; Oocyte Donation - legislation & jurisprudence; outcome; payment; Pregnancy; Registries; Sterility. Assisted procreation; Asia; Israel; insurance; cycles; payment; outcome; oocyte donation; Human; Assisted procreation; Female; Ovocyte donation; Cost analysis; Estimation; Empirical Approach; Legal Approach; Genetics and Reproduction
• ISSN: 0268-1161; 1460-2350; 1460-2350
• DOI: 10.1093/humrep/17.5.1404

BACKGROUND: Israeli law stipulates that all women aged 45–51 who need oocyte donation are entitled to as many donations as necessary, up to the birth of one child. Only oocytes donated by women who themselves are undergoing assisted reproduction are allowed. The government subsidises all oocyte donation cycles through the medical insurer of the recipient, whether or not the procedure is performed in a public or private institution. The aim of the present study was to investigate the success of oocyte donation cycles in Israel for the period 1998–2000 and to estimate costs and pregnancy rates. METHODS: Data were derived from the Dan District Registry of the General Health Services (Sheirutei Bri'ut Clalit), the largest medical insurer in Israel. RESULTS: 171 women underwent 254 oocyte donation cycles within these 3 years, and 45 babies were born, for a positive outcome of 17.7%. Average annual cycle cost was US$1742 and average annual cost per patient, US$2521. The total annual cost for the district accounted for only 0.05% of the budget. CONCLUSIONS: These findings suggest that IVF with donated oocytes is relatively efficient and that government funding of oocyte donation cycles ensures a reasonable cost.